This compound is primarily used in research settings as a potential antitumor agent. It shows activity in inhibiting the growth of certain cancer cell lines by interacting with DNA, leading to cell cycle arrest and apoptosis. Its structure allows for coordination to nucleic acids, making it of interest in the development of platinum-based chemotherapeutics. It is also studied for its unique ligand environment, which may influence solubility and reduce resistance mechanisms seen in other platinum drugs. Applications remain experimental, with ongoing studies to evaluate efficacy, toxicity, and delivery methods.